Recursion reports Phase 2 FAP data, Sanofi option, Hassan as new chairNov 2Quarterly updateREC-1245Recursion Pharmaceuticals, Inc.
Recursion prices $200M offering, reports Sanofi milestone and TUPELO, DAHLIA dataOct 15Quarterly updateAlector, Inc.REC-1245Updated
Sign inSign in